Skip to Search
Skip to Navigation
Skip to Main Content
Skip to Footer
About Us
Life Sciences Publications
Our Medicines
Topic Articles
Topic Discussions
Login
Google Translate
Select language
English
French
Spanish
Login
Username
*
Password
*
Staff Login
×
Google Translate
Select language
English
French
Spanish
Login
Menu
Site Search
Search Options
Resources
Everything
Advanced Search
Uptodate
All
Title Search
Author
Patients & Caregivers
Healthcare Providers
Researchers & Partners
Investors
menu
About Us
Life Sciences Publications
Our Medicines
Topic Articles
Topic Discussions
Google News
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Morgan Stanley Increases Sage Therapeutics (NASDAQ:SAGE) Price Target to $22.00 - AmericanBankingNEWS
Morgan Stanley Increases Sage Therapeutics (NASDAQ:SAGE) Price Target to $22.00 - AmericanBankingNews.com
Sage Therapeutics, Inc. (NASDAQ:SAGE) Holdings Lifted by Palo Alto Investors LP - MarketBeat
165,985 Shares in Sage Therapeutics, Inc. (NASDAQ:SAGE) Purchased by Federated Hermes Inc. - MarketBeat
FDA Decisions: Multiple Issues Cited in Rejection of Minerva’s Schizophrenia Hopeful - BioSpace
Peeling Back The Layers: Exploring Sage Therapeutics Through Analyst Insights - Markets Insider
Algert Global LLC Makes New $1.17 Million Investment in Sage Therapeutics, Inc. (NASDAQ:SAGE) - MarketBeat
Sage Therapeutics to Present at Upcoming March Investor Conferences - Winchester Herald Chronicle
Sage Therapeutics to Present at Upcoming March Investor Conferences - Elk Valley Times
Sage Therapeutics to Present at Upcoming March Investor Conferences - Yahoo Finance
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
next ›
last »
×